Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome

Abstract

Background and aims: There is a clear need for a rapid, simple, safe, and sensitive method of determining the type and intensity of inflammation in the gut mucosa in clinical practice. In this study, we have evaluated the potential of a new method, the mucosal patch technique, in patients with and without apparent gut inflammation, as assessed by conventional diagnostic procedures. Subjects and methods: The technique tested is based on the idea that inflammatory mediators released from the rectal mucosa can be absorbed by and then extracted from cellulose patches brought into contact with the mucosa by use of an instrument with an inflatable balloon. Measurements were performed in healthy controls (n = 16) and in patients with active (n = 19) and inactive ulcerative colitis (UC, n = 8), collagen colitis (CC, n = 12), coeliac disease (n = 13), and irritable bowel syndrome (IBS, n = 13). Results: Inflammatory mediators from neutrophils (myeloperoxidase (MPO)) and eosinophils (eosinophil cationic protein (ECP)) were increased on average 300-and 10-fold, respectively, in patients with active UC compared with healthy controls and were correlated with the endoscopic score. Patients with inactive UC, CC, coeliac disease, and IBS exhibited no endoscopic signs of inflammation. These patient groups had significantly lower levels of MPO and ECP than the active UC group but showed on average a four-to sevenfold increase in MPO compared with healthy controls. Conclusion: The mucosal patch technique was well tolerated by patients and easily applied by the investigator. Pronounced neutrophil and eosinophil involvement in UC was demonstrated. With the high sensitivity of the technique, low degree mucosal neutrophil activation could also be quantified in patients with CC and UC in clinical remission. The finding of increased neutrophil involvement in patients with IBS contributes to the pathophysiological ideas of this disease.

Preventive effects of enzyme-treated rice fiber in a restraint stress-induced irritable bowel syndrome model

“…Post-infectious low-grade mucosal inflammation is thought to be one of several possible causes of IBS in a specific subset of patients (4)(5)(6)(7). IBS has a heterogeneous clinical presentation that includes abnormal bowel movements and abdominal pain, which are also symptoms of inflammatory bowel disease (IBD) (8)(9)(10).…”

Assessment of eosinophils in gastrointestinal inflammatory disease of dogs

“…The presence of an increased number of degranulated eosinophils in the upper and lower LP may be a previously unrecognized feature of IBD. Previous studies indicate that eosinophil granule proteins (eg, eosinophil cationic protein, major basic protein) released by activated eosinophils contribute to tissue damage and inflammation during GI disorders and may be indicative of active ongoing disease 3, 10, 30, 33, 34…”

Measurements of Eosinophil Activation before and after Food Challenges in Adults with Food Hypersensitivity

“…Thus, several studies have demonstrated that normal values of IgE antibodies against food antigens in skin or serum do not exclude an intestinal food allergy [25, 26]. In the present study, we aimed to further investigate the role of inflammation markers in a single provocation model.…”